Nuclear medicine UK: signs of progress

Autor Josef Ell, Peter
Vydáno 2004

Radionuclides in Nephrology

Autor Ell, Peter Josef
Vydáno 1983

What’s up in nuclear medicine?

Autor Ell, Peter J.
Vydáno v Cancer Imaging (2015)

The contribution of medical physics to nuclear medicine: a physician's perspective

Autor Ell, Peter J
Vydáno v EJNMMI Phys (2014)

Editorial

Autor Ell, Peter J
Vydáno v Clin Med (Lond) (2006)

If I Were a Patient

Autor Ell, Peter Josef
Vydáno v J R Coll Physicians Lond (1993)

Management of Myocardial Infarction

Autor Ell, Peter Josef
Vydáno v J R Coll Physicians Lond (1994)

PET and SPECT in common neuropsychiatric disease

Autor Tatsch, Klaus, Ell, Peter J
Vydáno v Clin Med (Lond) (2006)

Atlas of lymphoscintigraphy and sentinel node mapping a pictorial case-based approach /

Autor Mariani, Giuliano, Ell, Peter Josef, Lucignani, Giovanni
Vydáno c201

18F-fluorodeoxyglucose PET/CT in cancer imaging

Autor Ell, Peter J, Kayani, Irfan, Groves, Ashley M
Vydáno v Clin Med (Lond) (2006)

Emission Tomography in Embolic Lung Disease

Autor Donaldson, Robert M., Khan, Omar, Bennett, J. Graeme, Ell, Peter J.
Vydáno 1982

Allergy to Technetium-Labelled Nanocolloidal Albumin for Sentinel Node Identification

Autor Chicken, Dennis W, Mansouri, Reza, Ell, Peter J, Keshtgar, Mohammed RS
Vydáno 2007

The role of (18)FDG PET/CT in the management of colorectal liver metastases

Autor Engledow, Alec H, Skipworth, James RA, Pakzad, Farrokh, Imber, Charles, Ell, Peter J, Groves, Ashley M
Vydáno 2012

Vasodilator myocardial perfusion imaging: demonstration of local electrophysiological changes of ischaemia

Autor John, Roy M, Taggart, Peter I, Sutton, Peter M, Costa, Durval C, Ell, Peter J, Swanton, Howard
Vydáno 1992

Integrated (18)F-Fluorodeoxyglucose–Positron Emission Tomography/Dynamic Contrast-Enhanced Computed Tomography to Phenotype Non–Small Cell Lung Carcinoma

Autor Shastry, Manu, Miles, Kenneth A., Win, Thida, Janes, Sam M., Endozo, Raymond, Meagher, Marie, Ell, Peter J., Groves, Ashley M.
Vydáno 2012

Exenatide and the treatment of patients with Parkinson’s disease

Autor Aviles-Olmos, Iciar, Dickson, John, Kefalopoulou, Zinovia, Djamshidian, Atbin, Ell, Peter, Soderlund, Therese, Whitton, Peter, Wyse, Richard, Isaacs, Tom, Lees, Andrew, Limousin, Patricia, Foltynie, Thomas
Vydáno 2013

Defining the Role of PET–CT in Staging Early Breast Cancer

Autor Groves, Ashley M., Shastry, Manu, Ben-Haim, Simona, Kayani, Irfan, Malhotra, Anmol, Davidson, Timothy, Kelleher, Tina, Whittaker, Diane, Meagher, Marie, Holloway, Brian, Warren, Ruth M., Ell, Peter J., Keshtgar, Mohammed R.
Vydáno 2012

Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients

Autor Win, Thida, Thomas, Benjamin A., Lambrou, Tryphon, Hutton, Brian F., Screaton, Nicholas J., Porter, Joanna C., Maher, Toby M., Endozo, Raymondo, Shortman, Robert I., Afaq, Asim, Lukey, Pauline, Ell, Peter J., Groves, Ashley M.
Vydáno 2013

Pulmonary (18)F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)

Autor Win, Thida, Screaton, Nicholas J., Porter, Joanna C., Ganeshan, Balaji, Maher, Toby M., Fraioli, Francesco, Endozo, Raymondo, Shortman, Robert I., Hurrell, Lynn, Holman, Beverley F., Thielemans, Kris, Rashidnasab, Alaleh, Hutton, Brian F., Lukey, Pauline T., Flynn, Aiden, Ell, Peter J., Groves, Ashley M.
Vydáno v Eur J Nucl Med Mol Imaging (2018)